• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

ASCO Physicians Consider Cost-Effectiveness of Expensive Oncology Drugs

Article

The world's largest organization of cancer doctors plans to rate the cost effectiveness of expensive oncology drugs, and will urge physicians to use the ratings to discuss the costs with their patients.

The American Society of Clinical Oncology is weighing efficacy, side effects and price using an algorithm to determine the relative value of drugs, focusing first on therapies for advanced cases of lung and prostate cancer and for multiple myeloma, said Richard Schilsky, the group’s chief medical officer. The task force developing the system plans to present it for public comment later this year, he said.

With the price of many cancer regimens reaching $10,000 a month, doctors need to communicate the medical implications of their care and, increasingly, the cost so patients can make the best decisions for themselves and their families, panel members said.

“Cancer is one of the primary reasons families go bankrupt today,” said Gary Lyman, an oncologist at the Fred Hutchinson Cancer Research Center in Seattle and a member of the task force. “Often families are mortgaging their houses to pay for these expensive drugs. We want to make sure families understand both the benefits of what we can do, and the financial impact.”

Read the complete report here: http://bloom.bg/1gHhjyY

Source: Bloomberg

Related Videos
Mila Felder, MD, FACEP
Kiana Mehring, MBA, director of strategic partnerships, managed care at Florida Cancer Specialists & Research Institute (FCS)
Miriam J. Atkins, MD, FACP, president of the Community Oncology Alliance (COA) and physician and partner of AO Multispecialty Clinic in Augusta, Georgia.
Dr Lucy Langer
Edward Arrowsmith, MD, MPH
Dr Kathi Mooney
Tiago Biachi de Castria, MD, PhD, Moffitt Cancer Center
Related Content
© 2024 MJH Life Sciences
AJMC®
All rights reserved.